Ms Robin Klebig from the Mayo Clinic in Rochester, Minnesota, discusses the emerging role of bispecific antibodies in the treatment of non-Hodgkin lymphoma. NCPD information and select publications <a href="https://www.researchtopractice.com/ONU2024/BispecificsLymphoma/1" rel="noopener noreferrer" target="_blank">here.</a>

Ms Robin Klebig from the Mayo Clinic in Rochester, Minnesota, discusses the emerging role of bispecific antibodies in the treatment of non-Hodgkin lymphoma. NCPD information and select publications here.

Ms Robin Klebig from the Mayo Clinic in Rochester, Minnesota, discusses the emerging role of bispecific antibodies in the treatment of non-Hodgkin lymphoma.&nbsp;NCPD information and select publications <a href="https://www.researchtopractice.com/ONU2024/BispecificsLymphoma/1" rel="noopener noreferrer">here.</a>

Bispecific Antibodies in Lymphoma Part 1 — An Interview with Ms Robin Klebig for Oncology Nurses

Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.

Share Bispecific Antibodies in Lymphoma Part 1 — An Interview with Ms Robin Klebig for Oncology Nurses

Sign up to save your podcasts

Bispecific Antibodies in Lymphoma Part 1 — An Interview with Ms Robin Klebig for Oncology Nurses

Bispecific Antibodies in Lymphoma Part 1 — An Interview with Ms Robin Klebig for Oncology Nurses